Home › Funds › Affinity Asset Advisors, LLC › TEVA

Affinity Asset Advisors, LLC position in TEVA

TEVA PHARMACEUTICAL INDS LTD · Health Care

Affinity Asset Advisors, LLC reported holding 374,000 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q2 2026 13F filing — a position valued at US$12.7M, representing 0.61% of its reported portfolio and ranking #48 among its reported holdings. Affinity Asset Advisors, LLC has disclosed TEVA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)374.00K sh
Reported value held$12.67M
Portfolio Weight0.61%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Affinity Asset Advisors, LLC's TEVA position evolved

Affinity Asset Advisors, LLC first disclosed a stake in TEVA in Q3 2023 at 1,100,000 shares (US$11.2M). The position peaked in Q4 2025 at 1,400,000 shares, worth US$43.7M. Across 12 filings, Affinity Asset Advisors, LLC increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 374,000 shares valued at US$12.7M — a reduction of -1,026,000 shares quarter over quarter.. Notable position changes include a 27% increase in Q4 2023 (shares rose 35% over the following quarter), a 40% increase in Q4 2024 (shares fell 30% over the following quarter), a 73% trim in Q2 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.10M $11.22M New
Q4 2023 1.40M $14.62M Add
Q1 2024 1.40M $19.75M Hold
Q2 2024 1.15M $18.69M Reduce
Q3 2024 1.00M $18.02M Reduce
Q4 2024 1.40M $30.86M Add
Q1 2025 1.40M $21.52M Hold
Q2 2025 1.40M $23.46M Hold
Q3 2025 1.40M $28.28M Hold
Q4 2025 1.40M $43.69M Hold
Q1 2026 1.40M $42.17M Hold
Q2 2026 374.00K $12.67M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TEVA and 13F data

TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 43 other funds we track also report a position in TEVA — the largest reported positions include Harel Insurance Investments & Financial Services Ltd. (US$1.63B), Phoenix Financial Ltd. (US$1.45B), WCM INVESTMENT MANAGEMENT, LLC (US$1.38B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TEVA

All TEVA fund holders →

FAQ

How long has Affinity Asset Advisors, LLC held TEVA?

Affinity Asset Advisors, LLC has disclosed TEVA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Affinity Asset Advisors, LLC's current position in TEVA?

As of Q2 2026, Affinity Asset Advisors, LLC holds 374.00K shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $12.67M, representing 0.61% of its reported portfolio and ranking #48.

Has Affinity Asset Advisors, LLC been buying or selling TEVA?

In the latest 13F filing (Q2 2026), Affinity Asset Advisors, LLC reduced its position in TEVA. The position peaked in Q4 2025 at 1.40M shares.

Which other funds hold TEVA?

Other major institutional holders of TEVA include Harel Insurance Investments & Financial Services Ltd., Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.